Atherosclerosis: Molecular Mechanisms, Genomic Modifiers and Therapeutic Strategies
The aim of the course is to provide attendees with a comprehensive understanding of atherosclerosis and strengthen the atherosclerosis research community. The course covers various aspects of the disease, including pathology, imaging techniques, epidemiology, risk assessment, prevention, treatment, genetic factors, animal models, and atherosclerosis research in industry.
Info about event
Time
Location
Comwell Klarskovgaard, Korsør
Organizer
This course is aimed at researchers in the field of atherosclerosis and aims to provide attendees with a comprehensive understanding of the disease.
The course will bring together students and top researchers from Denmark and abroad to provide lectures and facilitate discussion, strengthening the atherosclerosis research community. The course covers various aspects of atherosclerotic cardiovascular disease, including pathology, imaging techniques, epidemiology, risk assessment, prevention, treatment, genetic factors, animal models, and atherosclerosis research in industry. The program concludes with a networking lunch from 12.00 pm to 1.00 pm on the final day, offering attendees the opportunity to connect with their peers, exchange knowledge, and build relationships.
Format:
A mix of lectures, student presentations, group work, poster presentations and networking activities.
Learning outcomes
Upon completion of this course, participants will be able to:
- Discuss the development of the atherosclerotic lesion at the cellular and molecular level
- Relate risk factors to the pathology of atherosclerosis
- Describe options for risk prediction, prevention, and treatment
- Discuss the influence of genetic factors on the development of atherosclerosis
- Motivate the use of in vitro- and in vivo models to study atherosclerosis and apply them to a given project
- Identify ways to enhance atherosclerosis research quality through collaboration
Who can attend:
Research year students, master students, PhD students, postdoctoral fellows and senior researchers conducting research in atherosclerosis.
ECTS
Participation will give 1,5 ECTS points (at SDU pre-approved - at other universities application for ECTS is necessary)
Confirmed speakers:
- Jacob Fog Bentzon, Aarhus University (Aarhus, Denmark)
- Jan Borén, University of Gothenburg (Gothenburg, Sweden)
- Michael Nyberg, Department of Vascular Biology, Novo Nordisk (Måløv, Denmark)
- Martin Bødtker Mortensen, Aarhus University Hospital (Aarhus, Denmark)
- Rosh Al-Mashhadi, Aarhus University Hospital (Aarhus, Denmark)
- Maria Sabater-Lleal, Sant Pau Biomedical Researche Institute (Barcelona, Spain)
- Helle Jørgensen, Cambridge University (Cambridge, UK)
- Daniel Ketelhuth, University of Southern Denmark (Odense, Denmark)
- José Javier Fuster, CNIC (Madrid, Spain)
- Anton Gisterå, Karolinska Institute (Stockholm, Sweden)
- Lars Melholt Rasmusen, Odense University Hospital (Odense, Denmark)
- Claudia Monaco, Oxford University (Oxford, UK)
- Elena Aikawa, Harvard Medical School (Boston, USA)
Organizing committee:
- Lasse Bach Steffensen, Postdoc, SDU
- Laura Alonso Herranz, Postdoc, AU
- Julián Albarrán-Juárez, assistant Professor, AU
- Lasse Møllegaard Obel, PhD student, SDU
- Lars Melholt Rasmussen, Professor, OUH
- Jacob Fog Bentzon, Professor, AUH
- Daniel F. J. Ketelhuth, Professor, SDU